⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTX News
Nkarta, Inc. Common Stock
Nkarta to Participate in March Investor Conferences
globenewswire.com
NKTX
NÖK Therapeutics to Participate in BIO Investment & Growth Summit in Miami
globenewswire.com
NKTX
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
globenewswire.com
ABEO
NKTX
NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2/4 Dual Degrader for Cancer Therapy at SABCS 2025
businesswire.com
NKTX
Nkarta to Participate in Evercore Healthcare Conference
globenewswire.com
NKTX
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights
globenewswire.com
NKTX
Nkarta to Participate in November Investor Conferences
globenewswire.com
NKTX